GE HealthCare Receives FDA Clearance For Photonova Spectra, PCCT Solution Powered By Deep Silicon Detector Technology And Offered As Flexible Platform With Multiple Configurations To Meet Diverse Clinical Needs

GE HealthCare has received FDA clearance for its Photonova Spectra, a photon-counting computed tomography (PCCT) solution utilizing Deep Silicon detector technology. This clearance follows the product's debut at the RSNA 2025 Annual Meeting and is part of a $5.1 billion innovation investment aimed at driving 1-2% revenue growth. Photonova Spectra features 8-bin energy resolution and a universal workflow designed to enhance efficiency across various CT exams.